TriMark Publications Research

TriMark Publications is a premium market-research and publishing company providing original reports in the biotechnology, medical device, diagnostic and healthcare segments. Clients benefit from an expert, objective source for their research needs, saving time and resources.

TriMark Publications' reports are wide-ranging research publications that explore development activity, recent advances, and emerging trends in health care markets. In addition to our in-house proprietary database, the TriMark staff seeks out experts in the field, conducting extensive secondary research, and develops the findings into a cohesive, well-documented written analysis. Their specialty is constant staff review of reports to continually add and revise so that each report is absolutely up to date.

TriMark Publications Research
 

List of reports from TriMark Publications Research

< prev 1    3  
Diabetes, Metabolic Syndrome and Cardiovascular Disease
11/1/2014 | published by: TriMark Publications
... primarily a childhood disease--sometimes referred to as juvenile diabetes, now mostly Type 1 diabetes--the obesity crisis linked to the adoption of a high-fat, high-carbohydrate, high-calorie American diet has resulted in skyrocketing rates of diabetes among ...  |  read more...
USD 3,400
Molecular Diagnostics in Infectious Disease Testing
9/1/2014 | published by: TriMark Publications
... molecular diagnostics in infectious disease testing offers one of the most promising areas for growth and innovation. The confluence of breakthroughs in genomics and proteomics--along with the development of microarray devices to measure analytes in ...  |  read more...
USD 3,400
U.S. Glucose Testing Markets
7/1/2014 | published by: TriMark Publications
... industry is mature, several segments of the market, such as home testing devices for diabetes management and point of care (POC) instruments for use in professional settings, will exhibit strong growth. Direct access testing has ...  |  read more...
USD 3,400
World Glucose Self-Testing Markets
7/1/2014 | published by: TriMark Publications
... glucose self-testing products is undergoing a significant transition driven by the advent of new analytical technologies and new recommendations for tight glucose control for monitoring diabetes. In addition, the proliferation of the middle class within ...  |  read more...
USD 3,400
Hemoglobin A1c Testing Markets
7/1/2014 | published by: TriMark Publications
... than 366 million diabetics worldwide, hemoglobin A1c testing is now an essential assay in the diabetes testing repertoire. Its clinical utility and improvements in its accuracy and implementation of standardized protocols have translated into continued ...  |  read more...
USD 3,400
Biomarker Technology Platforms for Cancer Diagnoses and Therapies
7/1/2014 | published by: TriMark Publications
... early detection and diagnosis. In the major solid cancer types such as lung, breast, colon and prostate, long-term survival rates drop precipitously once metastatis has occurred. The case is clear for development of biomarkers for ...  |  read more...
USD 3,400
Companion Diagnostics in Personalized Medicine and Cancer Therapy
6/1/2014 | published by: TriMark Publications
... be important in the therapeutic application and clinical outcome of a drug, such as with personalized medicine for oncology patients. The molecular diagnostics field plays a vital part in personalized medicine and has greatly expanded ...  |  read more...
USD 3,400
Veterinary Health Markets
6/1/2014 | published by: TriMark Publications
... products continues to expand, encompassing anti-infectives, parasite controls, reproductive aids, metabolic drugs, feed additives, antibiotics, vaccines, topical solutions and imaging diagnostics as well as novel treatments for chronic conditions such as osteoarthritis, cardiovascular disease and ...  |  read more...
USD 3,400
Point of Care Diagnostic Testing World Markets
5/1/2014 | published by: TriMark Publications
... immediately, rather than waiting hours or even days for outside lab results to arrive. Point of care testing covers: blood glucose testing, blood gas and electrolytes analysis, rapid coagulation testing, rapid cardiac markers diagnostics, drugs ...  |  read more...
USD 3,400
Blood Glucose Testing and Diabetes Management
5/1/2014 | published by: TriMark Publications
... of as primarily a childhood disease--sometimes referred to as juvenile diabetes, now mostly Type 1 diabetes--the obesity crisis linked to the adoption of a high-fat, high-carbohydrate, high-calorie American diet has resulted in skyrocketing rates of ...  |  read more...
USD 3,400
Global Flow Cytometry Market
5/1/2014 | published by: TriMark Publications
... global flow cytometry market remains one of the fastest-growing segments of life sciences and clinical diagnostics markets. In the current life sciences research, pharmaceutical drug discovery and development, and clinical diagnostics markets, flow cytometry offers ...  |  read more...
USD 3,400
DNA Sequencing and PCR Markets
11/1/2013 | published by: TriMark Publications
... competitive, driven by rapid technological advancements and aggressive price wars. Next-generation sequencing presents an exciting area of growth for life science tool vendors, including those providing sequencers, ancillary instrumentation, reagents and software. This TriMark Publications ...  |  read more...
USD 3,400
Molecular Diagnostics in Genetic Testing
11/1/2013 | published by: TriMark Publications
... microarray devices to measure analytes in the blood and various body tissues are driving significant growth in the segment. Major developments include the integration of specialty labs and gene expression profiling into clinical practice, the ...  |  read more...
USD 3,400
Molecular Diagnostics Markets
11/1/2013 | published by: TriMark Publications
... molecules, the screening and diagnosis of patients, and the optimization of drug therapy. In the past few years, this rapidly evolving field has seen several fascinating developments. This TriMark Publications report describes the specific market ...  |  read more...
USD 3,400
Molecular Diagnostics in Cancer Testing
11/1/2013 | published by: TriMark Publications
... first-generation amplification, DNA probes, fluorescent in-situ hybridization (FISH), second-generation biochips and microfluidics, next-generation signal detection, biosensors and molecular labels, and gene expression profiling using microarrays. These technologies are improving the discovery of therapeutic molecules for ...  |  read more...
USD 3,400
High-Growth Diagnostic Testing Markets
11/1/2013 | published by: TriMark Publications
... clinic and also to lower its costs. Clinical labs experienced a substantial growth during the last decade. The emphasis in this TriMark Publications report is on those companies that are actively developing and marketing high-growth ...  |  read more...
USD 3,400
Drugs of Abuse Testing Markets
11/1/2013 | published by: TriMark Publications
... abuse testing offers promise for significant growth and innovation. Examined in this study are assays for alcohol, cannabinoids, cocaine, amphetamines, opiates and phencyclidine, as well as assays for addictive prescription drugs such as OxyContin. Moreover, ...  |  read more...
USD 3,400
Microscopy Markets
10/1/2013 | published by: TriMark Publications
... emerging Atomic Force Microscopy (AFM) and Raman confocal systems, but traditional techniques will in reality continue to thrive as they contribute to a growing trend toward correlative microscopy in which multiple microscopy and/or spectroscopy techniques ...  |  read more...
USD 3,400
Bioseparation Systems for Global Biopharmaceutical Markets
8/1/2013 | published by: TriMark Publications
... global biomanufacturing capacity. Blockbuster biologics are going off patent, leaving the market open for developing and manufacturing low cost biosimilars. This TriMark Publications report, Bioseparation Systems for Global Biopharmaceutical Markets ,¬†provides market revenue size and ...  |  read more...
USD 3,400
Biologics and Biosimilars World Markets
8/1/2013 | published by: TriMark Publications
... subsequent entry biologics (SEBs), biosimilars are to biologics what generics are to branded drugs; they lower healthcare expenditures. This TriMark Publications report, Biologics and Biosimilars World Markets ,¬†describes the emergence of biologics and biosimilars and ...  |  read more...
USD 3,400
Stem Cell Markets
8/1/2013 | published by: TriMark Publications
... have been classified as either embryonic, adult (tissue-specific or cord blood) stem cells. Recent understanding of stem cell biology may provide new approaches for the treatment of a number of diseases as well as tissue/organ ...  |  read more...
USD 3,400
Companion Biomarkers in Drug Development
8/1/2013 | published by: TriMark Publications
... companion biomarker can be useful in ameliorating the regulatory process for the drug, or acting as an aid to therapeutic use in the clinic. Market opportunities for companion biomarkers are focused in drug development targets, ...  |  read more...
USD 3,400
Medical Imaging Markets
6/1/2013 | published by: TriMark Publications
... X-ray, ultrasound, computed tomography (CT), positron emission tomography (PET), single photon emission tomography (SPECT), magnetic resonance imaging (MRI), nuclear medicine (NM), mammography and fluoroscopy. Globally, X-ray is the most frequently used imaging procedure with about ...  |  read more...
USD 3,400
Disposable Syringe Markets
6/1/2013 | published by: TriMark Publications
... administer medications. This analysis is intended to provide basic market data pertaining to the U.S. and worldwide market segments. Each market segment is analyzed to determine size, growth rates, sales projections and factors influencing growth ...  |  read more...
USD 3,400
Cancer Diagnostic Testing World Markets
5/1/2013 | published by: TriMark Publications
... million Americans have or have had some form of cancer. Overall costs of the disease are $126 billion annually. Pharmaceutical companies are developing more than 300 new medicines for cancer, some of which are in ...  |  read more...
USD 3,400
< prev 1    3  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!